Discontinued — last reported Q4 '17
Finite Lived Intangible Assets - Gross
AbbVie Finite Lived Intangible Assets - Gross decreased by 1.1% to $89.48B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.6%, from $90.04B to $89.48B. Over 4 years (FY 2020 to FY 2024), Finite Lived Intangible Assets - Gross shows relatively stable performance with a -1.6% CAGR.
Analysis
How to read this metric
An increase typically signals recent strategic acquisitions or significant investment in intellectual property, while a decrease reflects asset retirement or impairment.
Detailed definition
This is the total historical cost of intangible assets with a defined useful life, such as patents, trademarks, and acqu...
Peer comparison
Large healthcare companies frequently carry significant gross intangible assets due to the high volume of M&A activity in the sector.
finite_lived_intangible_assets_grossHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $96.26B | $96.37B | $97.43B | $97.30B | $96.93B | $95.80B | $96.17B | $96.10B | $96.18B | $84.79B | $83.33B | $90.54B | $89.81B | $90.04B | $89.74B | $89.99B | $90.50B | $89.48B |
| QoQ Change | — | +0.1% | +1.1% | -0.1% | -0.4% | -1.2% | +0.4% | -0.1% | +0.1% | -11.8% | -1.7% | +8.6% | -0.8% | +0.3% | -0.3% | +0.3% | +0.6% | -1.1% |
| YoY Change | — | — | — | — | +0.7% | -0.6% | -1.3% | -1.2% | -0.8% | -11.5% | -13.4% | -5.8% | -6.6% | +6.2% | +7.7% | -0.6% | +0.8% | -0.6% |
Finite Lived Intangible Assets - Gross at Other Companies
Frequently Asked Questions
- What is AbbVie's finite lived intangible assets - gross?
- AbbVie (ABBV) reported finite lived intangible assets - gross of $89.48B in Q3 2025.
- How has AbbVie's finite lived intangible assets - gross changed year-over-year?
- AbbVie's finite lived intangible assets - gross decreased by 0.6% year-over-year, from $90.04B to $89.48B.
- What is the long-term trend for AbbVie's finite lived intangible assets - gross?
- Over 4 years (2020 to 2024), AbbVie's finite lived intangible assets - gross has grown at a -1.6% compound annual growth rate (CAGR), from $95.54B to $89.74B.
- What does finite lived intangible assets - gross mean?
- The total original cost of intangible assets that have a limited lifespan, before subtracting accumulated amortization.